Literature DB >> 23830731

Integrated high-resolution array CGH and SKY analysis of homozygous deletions and other genomic alterations present in malignant mesothelioma cell lines.

Geula Klorin1, Ester Rozenblum, Oleg Glebov, Robert L Walker, Yoonsoo Park, Paul S Meltzer, Ilan R Kirsch, Frederic J Kaye, Anna V Roschke.   

Abstract

High-resolution oligonucleotide array comparative genomic hybridization (aCGH) and spectral karyotyping (SKY) were applied to a panel of malignant mesothelioma (MMt) cell lines. SKY has not been applied to MMt before, and complete karyotypes are reported based on the integration of SKY and aCGH results. A whole genome search for homozygous deletions (HDs) produced the largest set of recurrent and non-recurrent HDs for MMt (52 recurrent HDs in 10 genomic regions; 36 non-recurrent HDs). For the first time, LINGO2, RBFOX1/A2BP1, RPL29, DUSP7, and CCSER1/FAM190A were found to be homozygously deleted in MMt, and some of these genes could be new tumor suppressor genes for MMt. Integration of SKY and aCGH data allowed reconstruction of chromosomal rearrangements that led to the formation of HDs. Our data imply that only with acquisition of structural and/or numerical karyotypic instability can MMt cells attain a complete loss of tumor suppressor genes located in 9p21.3, which is the most frequently homozygously deleted region. Tetraploidization is a late event in the karyotypic progression of MMt cells, after HDs in the 9p21.3 region have already been acquired. Published by Elsevier Inc.

Entities:  

Keywords:  Malignant mesothelioma; homozygous deletions; oligonucleotide array CGH; spectral karyotyping; tumor suppressors

Mesh:

Year:  2013        PMID: 23830731      PMCID: PMC4030604          DOI: 10.1016/j.cancergen.2013.04.006

Source DB:  PubMed          Journal:  Cancer Genet


  56 in total

1.  Nonrandom chromosome alterations in human malignant mesothelioma.

Authors:  N C Popescu; A P Chahinian; J A DiPaolo
Journal:  Cancer Res       Date:  1988-01-01       Impact factor: 12.701

2.  Frequent genomic loss at chr16p13.2 is associated with poor prognosis in colorectal cancer.

Authors:  Claus Lindbjerg Andersen; Philippe Lamy; Kasper Thorsen; Eigil Kjeldsen; Friedrik Wikman; Palle Villesen; Bodil Øster; Søren Laurberg; Torben Falck Ørntoft
Journal:  Int J Cancer       Date:  2011-03-11       Impact factor: 7.396

3.  Frequent deletion of 3p21.1 region carrying semaphorin 3G and aberrant expression of the genes participating in semaphorin signaling in the epithelioid type of malignant mesothelioma cells.

Authors:  Yoshie Yoshikawa; Ayuko Sato; Tohru Tsujimura; Tomonori Morinaga; Kazuya Fukuoka; Shusai Yamada; Aki Murakami; Nobuyuki Kondo; Seiji Matsumoto; Yoshitomo Okumura; Fumihiro Tanaka; Seiki Hasegawa; Tomoko Hashimoto-Tamaoki; Takashi Nakano
Journal:  Int J Oncol       Date:  2011-08-12       Impact factor: 5.650

4.  Second generation sequencing of the mesothelioma tumor genome.

Authors:  Raphael Bueno; Assunta De Rienzo; Lingsheng Dong; Gavin J Gordon; Colin F Hercus; William G Richards; Roderick V Jensen; Arif Anwar; Gautam Maulik; Lucian R Chirieac; Kim-Fong Ho; Bruce E Taillon; Cynthia L Turcotte; Robert G Hercus; Steven R Gullans; David J Sugarbaker
Journal:  PLoS One       Date:  2010-05-13       Impact factor: 3.240

5.  High-resolution characterization of the pancreatic adenocarcinoma genome.

Authors:  Andrew J Aguirre; Cameron Brennan; Gerald Bailey; Raktim Sinha; Bin Feng; Christopher Leo; Yunyu Zhang; Jean Zhang; Joseph D Gans; Nabeel Bardeesy; Craig Cauwels; Carlos Cordon-Cardo; Mark S Redston; Ronald A DePinho; Lynda Chin
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-15       Impact factor: 11.205

6.  Gene expression profiling and gene copy-number changes in malignant mesothelioma cell lines.

Authors:  Claudia Zanazzi; Remko Hersmus; Imke M Veltman; Ad J M Gillis; Ellen van Drunen; H Berna Beverloo; Joost P J J Hegmans; Marielle Verweij; Bart N Lambrecht; J Wolter Oosterhuis; Leendert H J Looijenga
Journal:  Genes Chromosomes Cancer       Date:  2007-10       Impact factor: 5.006

Review 7.  Advances in the molecular biology of malignant mesothelioma.

Authors:  Shinichi Toyooka; Takumi Kishimoto; Hiroshi Date
Journal:  Acta Med Okayama       Date:  2008-02       Impact factor: 0.892

8.  Codeletion of p15 and p16 in primary malignant mesothelioma.

Authors:  S Xio; D Li; J Vijg; D J Sugarbaker; J M Corson; J A Fletcher
Journal:  Oncogene       Date:  1995-08-03       Impact factor: 9.867

9.  Recurring loss involving chromosomes 1, 3, and 22 in malignant mesothelioma: possible sites of tumor suppressor genes.

Authors:  W L Flejter; F P Li; K H Antman; J R Testa
Journal:  Genes Chromosomes Cancer       Date:  1989-11       Impact factor: 5.006

10.  The promyelocytic leukemia zinc-finger gene, PLZF, is frequently downregulated in malignant mesothelioma cells and contributes to cell survival.

Authors:  M Cheung; J Pei; Y Pei; S C Jhanwar; H I Pass; J R Testa
Journal:  Oncogene       Date:  2009-12-14       Impact factor: 9.867

View more
  10 in total

1.  Screening for bladder cancer with urinary tumor markers in chemical workers with exposure to aromatic amines.

Authors:  Beate Pesch; Dirk Taeger; Georg Johnen; Katarzyna Gawrych; Nadine Bonberg; Christian Schwentner; Harald Wellhäusser; Matthias Kluckert; Gabriele Leng; Michael Nasterlack; Yair Lotan; Arnulf Stenzl; Thomas Brüning
Journal:  Int Arch Occup Environ Health       Date:  2013-10-16       Impact factor: 3.015

2.  Prevalent Homozygous Deletions of Type I Interferon and Defensin Genes in Human Cancers Associate with Immunotherapy Resistance.

Authors:  Zhenqing Ye; Haidong Dong; Ying Li; Tao Ma; Haojie Huang; Hon Sing Leong; Jeanette Eckel-Passow; Jean-Pierre A Kocher; Han Liang; Liguo Wang
Journal:  Clin Cancer Res       Date:  2018-04-04       Impact factor: 12.531

3.  Comparative Transcriptome Profiling Reveals Coding and Noncoding RNA Differences in NSCLC from African Americans and European Americans.

Authors:  Khadijah A Mitchell; Adriana Zingone; Leila Toulabi; Jacob Boeckelman; Bríd M Ryan
Journal:  Clin Cancer Res       Date:  2017-12-01       Impact factor: 12.531

4.  Gender-Specific Molecular and Clinical Features Underlie Malignant Pleural Mesothelioma.

Authors:  Assunta De Rienzo; Michael A Archer; Beow Y Yeap; Nhien Dao; Daniele Sciaranghella; Antonios C Sideris; Yifan Zheng; Alexander G Holman; Yaoyu E Wang; Paola S Dal Cin; Jonathan A Fletcher; Renee Rubio; Larry Croft; John Quackenbush; Peter E Sugarbaker; Kiara J Munir; Jesse R Battilana; Corinne E Gustafson; Lucian R Chirieac; Soo Meng Ching; James Wong; Liang Chung Tay; Stephen Rudd; Robert Hercus; David J Sugarbaker; William G Richards; Raphael Bueno
Journal:  Cancer Res       Date:  2015-11-10       Impact factor: 12.701

5.  The SNP rs6500843 in 16p13.3 is associated with survival specifically among chemotherapy-treated breast cancer patients.

Authors:  Rainer Fagerholm; Marjanka K Schmidt; Sofia Khan; Sajjad Rafiq; William Tapper; Kristiina Aittomäki; Dario Greco; Tuomas Heikkinen; Taru A Muranen; Peter A Fasching; Wolfgang Janni; Richard Weinshilboum; Christian R Loehberg; John L Hopper; Melissa C Southey; Renske Keeman; Annika Lindblom; Sara Margolin; Arto Mannermaa; Vesa Kataja; Georgia Chenevix-Trench; Diether Lambrechts; Hans Wildiers; Jenny Chang-Claude; Petra Seibold; Fergus J Couch; Janet E Olson; Irene L Andrulis; Julia A Knight; Montserrat García-Closas; Jonine Figueroa; Maartje J Hooning; Agnes Jager; Mitul Shah; Barbara J Perkins; Robert Luben; Ute Hamann; Maria Kabisch; Kamila Czene; Per Hall; Douglas F Easton; Paul D P Pharoah; Jianjun Liu; Diana Eccles; Carl Blomqvist; Heli Nevanlinna
Journal:  Oncotarget       Date:  2015-04-10

6.  A Biphasic Pleural Tumor with Features of an Epithelioid and Small Cell Mesothelioma: Morphologic and Molecular Findings.

Authors:  Sarah Hackman; Richard D Hammer; Lester Layfield
Journal:  Case Rep Pathol       Date:  2016-06-15

7.  CDKN2A copy number and p16 expression in malignant pleural mesothelioma in relation to asbestos exposure.

Authors:  Eeva Kettunen; Sauli Savukoski; Kaisa Salmenkivi; Tom Böhling; Esa Vanhala; Eeva Kuosma; Sisko Anttila; Henrik Wolff
Journal:  BMC Cancer       Date:  2019-05-28       Impact factor: 4.430

8.  Novel Gastric Cancer Stem Cell-Related Marker LINGO2 Is Associated with Cancer Cell Phenotype and Patient Outcome.

Authors:  Jung Hyun Jo; Soo Been Park; Semi Park; Hee Seung Lee; Chanyang Kim; Dawoon E Jung; Si Young Song
Journal:  Int J Mol Sci       Date:  2019-01-28       Impact factor: 5.923

9.  RBFOX1 Regulates the Permeability of the Blood-Tumor Barrier via the LINC00673/MAFF Pathway.

Authors:  Shuyuan Shen; Chunqing Yang; Xiaobai Liu; Jian Zheng; Yunhui Liu; Libo Liu; Jun Ma; Teng Ma; Ping An; Yang Lin; Heng Cai; Di Wang; Zhen Li; Lini Zhao; Yixue Xue
Journal:  Mol Ther Oncolytics       Date:  2020-03-30       Impact factor: 7.200

10.  DUSP7 inhibits cervical cancer progression by inactivating the RAS pathway.

Authors:  Huimin Bai; Meiying Song; Ruili Jiao; Weihua Li; Jing Zhao; Meizhu Xiao; Mulan Jin; Zhengyu Zhang; Haiteng Deng
Journal:  J Cell Mol Med       Date:  2021-08-26       Impact factor: 5.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.